WO2001031580A3 - Methods and devices for identifying patterns in biological systems - Google Patents

Methods and devices for identifying patterns in biological systems Download PDF

Info

Publication number
WO2001031580A3
WO2001031580A3 PCT/US2000/029770 US0029770W WO0131580A3 WO 2001031580 A3 WO2001031580 A3 WO 2001031580A3 US 0029770 W US0029770 W US 0029770W WO 0131580 A3 WO0131580 A3 WO 0131580A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
devices
biological systems
identifying patterns
patterns
Prior art date
Application number
PCT/US2000/029770
Other languages
French (fr)
Other versions
WO2001031580A2 (en
Inventor
Stephen D Barnhill
Isabelle Guyon
Jason Weston
Original Assignee
Biowulf Technologies Llc
Stephen D Barnhill
Isabelle Guyon
Jason Weston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/568,301 external-priority patent/US6427141B1/en
Priority claimed from US09/578,011 external-priority patent/US6658395B1/en
Application filed by Biowulf Technologies Llc, Stephen D Barnhill, Isabelle Guyon, Jason Weston filed Critical Biowulf Technologies Llc
Priority to AU12427/01A priority Critical patent/AU779635B2/en
Priority to CA2388595A priority patent/CA2388595C/en
Priority to JP2001534088A priority patent/JP5064625B2/en
Priority to EP00973988A priority patent/EP1236173A2/en
Publication of WO2001031580A2 publication Critical patent/WO2001031580A2/en
Publication of WO2001031580A3 publication Critical patent/WO2001031580A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/764—Arrangements for image or video recognition or understanding using pattern recognition or machine learning using classification, e.g. of video objects
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/774—Generating sets of training patterns; Bootstrap methods, e.g. bagging or boosting
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Epidemiology (AREA)
  • Bioethics (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Multimedia (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The methods, systems and devices of the present invention comprise use of support vector machines for the identification of patterns that are important for medical diagnosis, prognosis and treatment. Such patterns may be found in many different datasets. The present invention also comprises methods and compositions for the treatment and diagnosis of medical conditions.
PCT/US2000/029770 1999-10-27 2000-10-27 Methods and devices for identifying patterns in biological systems WO2001031580A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU12427/01A AU779635B2 (en) 1999-10-27 2000-10-27 Methods and devices for identifying patterns in biological systems and methods for uses thereof
CA2388595A CA2388595C (en) 1999-10-27 2000-10-27 Methods and devices for identifying patterns in biological systems and methods for uses thereof
JP2001534088A JP5064625B2 (en) 1999-10-27 2000-10-27 Method and machine for identifying patterns
EP00973988A EP1236173A2 (en) 1999-10-27 2000-10-27 Methods and devices for identifying patterns in biological systems

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US16180699P 1999-10-27 1999-10-27
US60/161,806 1999-10-27
US16870399P 1999-12-02 1999-12-02
US60/168,703 1999-12-02
US18459600P 2000-02-24 2000-02-24
US60/184,596 2000-02-24
US19121900P 2000-03-22 2000-03-22
US60/191,219 2000-03-22
US09/568,301 2000-05-09
US09/568,301 US6427141B1 (en) 1998-05-01 2000-05-09 Enhancing knowledge discovery using multiple support vector machines
US09/578,011 2000-05-24
US09/578,011 US6658395B1 (en) 1998-05-01 2000-05-24 Enhancing knowledge discovery from multiple data sets using multiple support vector machines
US20702600P 2000-05-25 2000-05-25
US60/207,026 2000-05-25

Publications (2)

Publication Number Publication Date
WO2001031580A2 WO2001031580A2 (en) 2001-05-03
WO2001031580A3 true WO2001031580A3 (en) 2002-07-11

Family

ID=27569077

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/029770 WO2001031580A2 (en) 1999-10-27 2000-10-27 Methods and devices for identifying patterns in biological systems

Country Status (5)

Country Link
EP (2) EP2357582A1 (en)
JP (1) JP5064625B2 (en)
AU (1) AU779635B2 (en)
CA (1) CA2388595C (en)
WO (1) WO2001031580A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0111742A (en) 2000-06-19 2004-02-03 Correlogic Systems Inc Heuristic Classification Method
EP1386275A2 (en) 2000-07-18 2004-02-04 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
CN1262337C (en) 2000-11-16 2006-07-05 赛弗根生物系统股份有限公司 Method for analyzing mass spectra
KR20030032395A (en) * 2001-10-24 2003-04-26 김명호 Method for Analyzing Correlation between Multiple SNP and Disease
WO2004011905A2 (en) 2002-07-29 2004-02-05 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
US9342657B2 (en) * 2003-03-24 2016-05-17 Nien-Chih Wei Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles
US6977370B1 (en) 2003-04-07 2005-12-20 Ciphergen Biosystems, Inc. Off-resonance mid-IR laser desorption ionization
US7341838B2 (en) 2003-04-17 2008-03-11 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
EP2369348A1 (en) 2003-11-07 2011-09-28 Ciphergen Biosystems, Inc. Biomarkers for Alzheimer's disease
ATE525478T1 (en) 2003-12-05 2011-10-15 Univ Mcgill SERUM BIOMARKER FOR CHAGAS DISEASE
EP1709442A4 (en) 2003-12-11 2010-01-20 Correlogic Systems Inc Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
WO2005098446A2 (en) 2004-03-31 2005-10-20 The Johns Hopkins University Biomarkers for ovarian cancer
EP1743031A4 (en) 2004-04-26 2008-05-28 Childrens Medical Center Platelet biomarkers for the detection of disease
CA2593184A1 (en) 2005-01-06 2006-07-13 Eastern Virginia Medical School Apolipoprotein a-ii isoform as a biomarker for prostate cancer
US20100197561A1 (en) 2005-06-24 2010-08-05 Ciphergen Biosystems, Inc. Biomarkers for Ovarian Cancer: B2 Microglobulin
EP1996949A4 (en) 2006-03-11 2010-01-20 Univ Leland Stanford Junior Beta-2 microglobulin as a biomarker for peripheral artery disease
JP5307996B2 (en) * 2006-09-06 2013-10-02 株式会社Ｄｎａチップ研究所 Method, system and computer software program for identifying discriminant factor set
AU2008236810A1 (en) 2007-03-27 2008-10-16 Board Of Regents Of The University Of Texas System Biomarkers for ovarian cancer
US20110091377A1 (en) 2007-05-11 2011-04-21 The Johns Hopkins University Biomarkers for melanoma
US8664358B2 (en) 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
EP2220506B1 (en) 2007-10-29 2013-10-02 Vermillion, Inc. Biomarkers for the detection of early stage ovarian cancer
JP5425814B2 (en) * 2008-02-08 2014-02-26 ヘルス ディスカバリー コーポレイション Method and system for analyzing flow cytometry data using a support vector machine
JP5533662B2 (en) * 2008-10-30 2014-06-25 コニカミノルタ株式会社 Information processing device
DE112009002693A5 (en) * 2008-11-26 2013-01-10 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method and device for automatic analysis of models
US8972899B2 (en) 2009-02-10 2015-03-03 Ayasdi, Inc. Systems and methods for visualization of data analysis
US9367812B2 (en) * 2010-08-25 2016-06-14 Optibrium Ltd. Compound selection in drug discovery
JP6071886B2 (en) 2010-10-14 2017-02-01 ザ・ジョンズ・ホプキンス・ユニバーシティ Brain injury biomarkers
EP2660310A4 (en) * 2010-12-28 2015-09-30 Tashiro Kei Comprehensive glaucoma determination method utilizing glaucoma diagnosis chip and deformed proteomics cluster analysis
JP5672035B2 (en) * 2011-02-03 2015-02-18 富士通株式会社 Input parameter calculation method, apparatus and program
US9771617B2 (en) 2011-06-27 2017-09-26 Eisai R&D Management Co., Ltd. Microrna biomarkers indicative of alzheimer's disease
MX361457B (en) 2012-05-11 2018-12-06 Reset Therapeutics Inc Carbazole-containing sulfonamides as cryptochrome modulators.
US10865446B2 (en) 2012-11-02 2020-12-15 The Johns Hopkins University DNA methylation biomarkers of post-partum depression risk
CA2914918C (en) 2013-05-10 2023-10-10 Johns Hopkins University Compositions and methods for ovarian cancer assessment having improved specificity
CA2918054C (en) 2013-07-11 2022-12-13 The Johns Hopkins University A dna methylation and genotype specific biomarker of suicide attempt and/or suicide ideation
EP3757226A3 (en) 2013-07-17 2021-05-05 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
US10619210B2 (en) 2014-02-07 2020-04-14 The Johns Hopkins University Predicting response to epigenetic drug therapy
TWI690521B (en) 2014-04-07 2020-04-11 美商同步製藥公司 Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators
WO2016044697A1 (en) 2014-09-19 2016-03-24 The Johns Hopkins University Biomarkers of cognitive dysfunction
US11072828B2 (en) 2014-10-06 2021-07-27 The Johns Hopkins University DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder
WO2016134365A1 (en) 2015-02-20 2016-08-25 The Johns Hopkins University Biomarkers of myocardial injury
CA3090392C (en) * 2015-12-07 2021-06-01 Zymergen Inc. Microbial strain improvement by a htp genomic engineering platform
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
US10748277B2 (en) 2016-09-09 2020-08-18 Siemens Healthcare Gmbh Tissue characterization based on machine learning in medical imaging
WO2018163435A1 (en) * 2017-03-10 2018-09-13 Omron Corporation Generating learning data
US10984334B2 (en) * 2017-05-04 2021-04-20 Viavi Solutions Inc. Endpoint detection in manufacturing process by near infrared spectroscopy and machine learning techniques
US20190034594A1 (en) * 2017-07-31 2019-01-31 National Cardiac, Inc. Computer-based systems and methods for monitoring the heart muscle of a patient with comprehensive contextual oversight
JP7437303B2 (en) 2017-12-29 2024-02-22 アボット・ラボラトリーズ Novel biomarkers and methods for diagnosing and assessing traumatic brain injury
CN108346144B (en) * 2018-01-30 2021-03-16 哈尔滨工业大学 Automatic bridge crack monitoring and identifying method based on computer vision
WO2019213619A1 (en) 2018-05-04 2019-11-07 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
KR102245270B1 (en) * 2019-02-25 2021-04-26 서강대학교 산학협력단 Method for oversampling minority category for training data
SG11202108707WA (en) 2019-02-27 2021-09-29 Epiaxis Therapeutics Pty Ltd Methods and agents for assessing t-cell function and predicting response to therapy
CN110189151A (en) * 2019-06-12 2019-08-30 北京奇艺世纪科技有限公司 A kind of account detection method and relevant device
JP7310673B2 (en) * 2020-03-23 2023-07-19 横河電機株式会社 Data management system, data management method, and data management program
US20220093252A1 (en) * 2020-09-23 2022-03-24 Sanofi Machine learning systems and methods to diagnose rare diseases
WO2023122723A1 (en) 2021-12-23 2023-06-29 The Broad Institute, Inc. Panels and methods for diagnosing and treating lung cancer
WO2024044578A1 (en) 2022-08-22 2024-02-29 University Of Virginia Dna methylation biomarkers of premenstrual dysphoric disorder and perimenopausal depression
CN116582133B (en) * 2023-07-12 2024-02-23 东莞市联睿光电科技有限公司 Intelligent management system for data in transformer production process

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022019A1 (en) * 1997-10-29 1999-05-06 Rutgers, The State University Of New Jersey Linking gene sequence to gene function by three-dimensional (3d) protein structure determination
WO1999053101A1 (en) * 1998-04-13 1999-10-21 Isis Pharmaceuticals, Inc. Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
WO1999057622A2 (en) * 1998-05-01 1999-11-11 Barnhill Technologies, Llc Pre-processing and post-processing for enhancing knowledge discovery using support vector machines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5649068A (en) 1993-07-27 1997-07-15 Lucent Technologies Inc. Pattern recognition system using support vectors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022019A1 (en) * 1997-10-29 1999-05-06 Rutgers, The State University Of New Jersey Linking gene sequence to gene function by three-dimensional (3d) protein structure determination
WO1999053101A1 (en) * 1998-04-13 1999-10-21 Isis Pharmaceuticals, Inc. Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
WO1999057622A2 (en) * 1998-05-01 1999-11-11 Barnhill Technologies, Llc Pre-processing and post-processing for enhancing knowledge discovery using support vector machines

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AMARI S ET AL: "Improving support vector machine classifiers by modifying kernel functions", NEURAL NETWORKS, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 12, no. 6, July 1999 (1999-07-01), pages 783 - 789, XP004174075, ISSN: 0893-6080 *
MORIK K ET AL: "COMBINING STATISTICAL LEARNING WITH A KNOWLEDGE-BASED APPROACH -A CASE STUDY IN INTENSIVE CARE MONITORING", MACHINE LEARNING. PROCEEDINGS OF THE INTERNATIONAL CONFERENCE, XX, XX, 27 June 1999 (1999-06-27), pages 268 - 277, XP001030158 *
SUGAYA S ET AL: "Support vector machines for knowledge discovery", PRINCIPLES OF DATA MINING AND KNOWLEDGE DISCOVERY. THIRD EUROPEAN CONFERENCE, PKDD'99. PROCEEDINGS. (LECTURE NOTES IN ARTIFICIAL INTELLIGENCE VOL.1704), PRINCIPLES OF DATA MINING AND KNOWLEDGE DISCOVERY. THIRD EUROPEAN CONFERENCE, PKDD'99, PRAGUE, CZ, 1999, Berlin, Germany, Springer-Verlag, Germany, pages 561 - 567, XP001030152, ISBN: 3-540-66490-4 *

Also Published As

Publication number Publication date
EP2357582A1 (en) 2011-08-17
WO2001031580A2 (en) 2001-05-03
JP2003529131A (en) 2003-09-30
AU779635B2 (en) 2005-02-03
JP5064625B2 (en) 2012-10-31
EP1236173A2 (en) 2002-09-04
CA2388595A1 (en) 2001-05-03
AU1242701A (en) 2001-05-08
CA2388595C (en) 2010-12-21

Similar Documents

Publication Publication Date Title
WO2001031580A3 (en) Methods and devices for identifying patterns in biological systems
WO2001031579A3 (en) Methods and devices for identifying patterns in biological patterns
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
WO2001036977A8 (en) Identification of disease markers involving mass-based-separation
WO2002059822A3 (en) Methods of identifying patterns in biological systems and uses thereof
AU3912700A (en) Method and system for healthcare treatment, planning, and assessment
MY142089A (en) Polishing system comprising a highly branched polymer
CA2371589A1 (en) Identity-coded surface
AU2002366641A1 (en) Methods for inhibiting ocular processes
WO2002103103A3 (en) Fluorine-containing compounds and polymers derived therefrom
EP1800691A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
WO2002063005A3 (en) Lipid-associated molecules
ATE318328T1 (en) DIAGNOSTICS AND THERAPEUTIC PRODUCTS FOR OSTEOPOROSIS
AU2002257615A1 (en) Methods and devices for treating and/or processing data
WO2004087066A3 (en) Hif-1 inhibitors
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
EP1376359A3 (en) Handling configuration information for network storage devices
AU2002219137A1 (en) Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
EP1363528A4 (en) Methods for diagnosing and treating heart disease
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
WO2001046443A3 (en) Proteases
NZ514691A (en) Method to type prion proteins
WO2003091690A3 (en) Cancer-associated nucleic acids and polypeptides
WO2002072883A3 (en) Nucleotide carrier for diagnosing and treating oral diseases
WO2003028647A3 (en) Identification of genes involved in restenosis and in atherosclerosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2388595

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 534088

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000973988

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12427/01

Country of ref document: AU

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000973988

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 12427/01

Country of ref document: AU

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)